Table 4.
Clinicopathological features | n | LVD | P‐value |
---|---|---|---|
Gender | |||
Male | 45 | 11.3 ± 4.7 | 0.686 |
Female | 25 | 10.8 ± 5.0 | |
Tumor location | |||
Head of pancreas/lesser pancreas | 50 | 10.9 ± 4.7 | 0.601 |
Body and tail of pancreas | 20 | 11.6 ± 5.1 | |
Tumor size | |||
Diameter ≥4.0 cm | 40 | 11.0 ± 4.4 | 0.821 |
Diameter <4.0 cm | 30 | 11.2 ± 5.3 | |
Tumor differentiation | |||
High or middle | 48 | 11.0 ± 5.0 | 0.800 |
Low | 22 | 11.3 ± 4.3 | |
Lymphatic vessel invasion in adjacent tissue | |||
Positive | 41 | 12.2 ± 4.8 | 0.024 |
Negative | 29 | 9.6 ± 4.4 | |
Lymph node metastasis | |||
Positive | 37 | 11.4 ± 4.4 | 0.549 |
Negative | 33 | 10.8 ± 5.2 | |
PNP invasion | |||
Positive | 47 | 11.9 ± 4.6 | 0.042 |
Negative | 23 | 9.4 ± 4.9 | |
VEGF‐C expression | |||
Positive | 43 | 12.1 ± 4.7 | 0.031 |
Negative | 27 | 9.6 ± 4.6 |
Lymphatic vessel density (LVD) data are given as the mean ± SD. PNP, peripancreatic nerve plexus; VEGF‐C, vascular endothelial growth factor C.